BIT:REC - Euronext Milan - IT0003828271 - Common Stock - Currency: EUR
BIT:REC (3/7/2025, 7:00:00 PM)
53.55
0 (0%)
The current stock price of REC.MI is 53.55 EUR. In the past month the price decreased by -8.62%. In the past year, price increased by 1.31%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
SNW.DE | SANOFI | 14.32 | 275.64B | ||
SAN.PA | SANOFI | 14.27 | 274.84B | ||
1SAN.MI | SANOFI | 14.19 | 273.18B | ||
6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
PFE.DE | PFIZER INC | 8.69 | 140.81B |
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. The company is headquartered in Milan, Milano and currently employs 4,455 full-time employees. The company promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The firm is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. The company operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The firm owns and operates through Natural Point srl also in the food supplement sector.
RECORDATI INDUSTRIA CHIMICA
Via Matteo Civitali, 1
Milan MILANO IT
Employees: 4455
Company Website: https://recordati.com/
Investor Relations: http://recordati.com/highlights-and-events/
Phone: 3902487871
The current stock price of REC.MI is 53.55 EUR.
The exchange symbol of RECORDATI INDUSTRIA CHIMICA is REC and it is listed on the Euronext Milan exchange.
REC.MI stock is listed on the Euronext Milan exchange.
15 analysts have analysed REC.MI and the average price target is 58.38 EUR. This implies a price increase of 9.03% is expected in the next year compared to the current price of 53.55. Check the RECORDATI INDUSTRIA CHIMICA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
RECORDATI INDUSTRIA CHIMICA (REC.MI) has a market capitalization of 11.20B EUR. This makes REC.MI a Large Cap stock.
RECORDATI INDUSTRIA CHIMICA (REC.MI) currently has 4455 employees.
RECORDATI INDUSTRIA CHIMICA (REC.MI) has a support level at 51.77 and a resistance level at 54.1. Check the full technical report for a detailed analysis of REC.MI support and resistance levels.
The Revenue of RECORDATI INDUSTRIA CHIMICA (REC.MI) is expected to grow by 11.55% in the next year. Check the estimates tab for more information on the REC.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RECORDATI INDUSTRIA CHIMICA (REC.MI) has a dividend yield of 2.3%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of REC.MI dividend history, reliability and sustainability.
RECORDATI INDUSTRIA CHIMICA (REC.MI) will report earnings on 2025-05-07.
The PE ratio for RECORDATI INDUSTRIA CHIMICA (REC.MI) is 27.32. This is based on the reported non-GAAP earnings per share of 1.96 and the current share price of 53.55 EUR. Check the full fundamental report for a full analysis of the valuation metrics for REC.MI.
ChartMill assigns a technical rating of 2 / 10 to REC.MI. When comparing the yearly performance of all stocks, REC.MI turns out to be only a medium performer in the overall market: it outperformed 44.22% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to REC.MI. While REC.MI has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months REC.MI reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS increased by 7.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.65% | ||
ROA | 10.07% | ||
ROE | 22.55% | ||
Debt/Equity | 0.69 |
ChartMill assigns a Buy % Consensus number of 69% to REC.MI. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 13.82% and a revenue growth 11.55% for REC.MI